Young Scientists Committed to Finding Treatments for Neurodegenerative Diseases
Andrew Mendiola, PhD named 2020 Berkelhammer Scholar
Andrew Mendiola, PhD named 2020 Berkelhammer Scholar
Illustration of amyloid plaques on a nerverticale cell.
Andrew Mendiola, PhD featured in Momentum, the official magazine of the National MS Society
Gladstone researchers Jae Kyu Ryu, Katerina Akassoglou, and Andrew Mendiola developed a novel method to profile toxic immune cells in the brain, and used it to identify a therapeutic target for multiple sclerosis.
Tox-seq revealed subtypes of brain immune cells that produce toxic reactive oxygen in a mouse model of MS.